神經血管設備市場規模、佔有率及成長分析（依疾病病理、最終用戶及地區）－2025 年至 2032 年產業預測

2023 年神經血管設備市場規模價值 37 億美元，預計將從 2024 年的 40.1 億美元成長到 2032 年的 77.1 億美元，預測期間（2025-2032 年）的複合年成長率為 8.5%。

受神經系統疾病和心血管疾病盛行率上升的推動，全球神經血管設備市場正在經歷顯著成長。人口老化和對神經血管疾病認知的提高進一步推動了對這些設備的需求。此外，向微創手術的轉變、醫療設備的技術進步以及對早期診斷的關注預計將推動市場擴張。急性缺血性腦中風的高發病率正在為全球設備製造商創造新的機會。然而，神經血管設備高成本、法律規範嚴格、新興市場准入有限以及潛在併發症等挑戰可能會長期阻礙市場發展。總體而言，該市場具有良好的成長潛力，但需要克服這些障礙才能最大限度地發揮其前景。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 案例研究
• 客戶和購買標準分析
• 貿易分析

神經血管設備市場規模（依疾病病理及複合年成長率）（2025-2032）

• 市場概覽
• 腦動脈瘤
  • 栓塞線圈
  • 可拆裸線圈
  • 塗層可拆線圈
  • 導流裝置
  • 顱內支架
  • 微導管
  • 導管導引線
• 缺血性中風
  • 血栓切除裝置
  • 吸痰及吸痰設備
  • 血管勒除器
  • 微導管
  • 微導管導引線
  • 球囊導管
• 頸動脈狹窄
  • 頸動脈支架
  • 栓塞保護裝置
  • 球囊導管
• 動靜脈畸形和瘻管
  • 液態栓塞劑
  • 閉塞球囊導管
  • 微導管
• 其他疾病的病理學

神經血管設備市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和外科中心
• 門診治療中心
• 研究辦公室和學術機構

神經血管設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Acandis GmbH（Germany）
• Asahi Intecc Co. Ltd.（Japan）
• Imperative Care Inc.（United States）
• Integer Holdings Corporation（United States）
• Johnson & Johnson（United States）
• Medtronic plc（Ireland）
• MicroPort Scientific Corporation（China）
• Penumbra Inc.（United States）
• Perflow Medical Ltd.（Israel）
• Rapid Medical（Canada）
• Stryker Corporation（United States）
• Terumo Corporation（Japan）
• WL Gore & Associates（United States）
• Penumbra, Inc.（United States）（duplicate）
• Siemens Healthineers AG（Germany）
• Boston Scientific Corporation（United States）
• InspireMD, Inc.（Israel）

結論和建議

Neurovascular Devices Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.01 billion in 2024 to USD 7.71 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The global neurovascular devices market is witnessing significant growth driven by the rising incidence of neurological disorders and cardiovascular diseases. An aging population and increased awareness surrounding neurovascular disorders further propel demand for these devices. Additionally, the shift toward minimally invasive surgeries, technological advancements in medical devices, and a focus on early diagnosis are expected to enhance market expansion. High rates of acute ischemic stroke present new opportunities for device suppliers worldwide. However, challenges such as the high cost of neurovascular devices, stringent regulatory frameworks, limited access in developing regions, and potential complications may hinder long-term market development. Overall, while the market has promising growth potential, it must navigate these obstacles to maximize its outlook.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Devices Market Segments Analysis

Global Neurovascular Devices Market is segmented by Disease Pathology, End User and region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, Arteriovenous Malformation & Fistulas and Other Disease Pathologies. Based on End User, the market is segmented into Hospitals And Surgical Centers, Ambulatory Care Centers and Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Devices Market

The rising prevalence of neurovascular diseases, attributed to poor lifestyle choices and the widespread adoption of unhealthy habits, has led to a dramatic increase in the number of individuals affected by conditions like strokes and cerebral aneurysms globally. This growing incidence of neurovascular conditions is a significant driver fueling the demand for neurovascular devices. As more people seek medical interventions and solutions to address these escalating health issues, the market for neurovascular devices is expected to expand, providing opportunities for innovation and development in treatments aimed at managing and preventing such critical health challenges.

Restraints in the Neurovascular Devices Market

The Neurovascular Devices market faces a significant challenge due to the exorbitant costs associated with these advanced medical technologies. While developed countries may manage these expenses, healthcare institutions in developing nations often operate within constrained budgets, hindering their ability to procure such specialized devices. This financial barrier limits access to essential treatments and innovations in neurovascular care, potentially exacerbating healthcare disparities between different regions. As a result, the high costs of these devices may restrict their widespread adoption, ultimately impeding advancements in patient care and outcomes in less affluent healthcare systems.

Market Trends of the Neurovascular Devices Market

The Neurovascular Devices market is witnessing a significant shift towards the development of minimally invasive technologies, driven by a global preference for procedures that offer quicker recovery times and enhanced patient comfort. As healthcare professionals and patients increasingly seek alternatives to traditional surgical techniques, manufacturers are strategically investing in the innovation of neurovascular devices that facilitate less invasive interventions. This trend not only enhances treatment efficacy but also addresses the burgeoning demand for efficient healthcare solutions. Consequently, companies focusing on the advancement of minimally invasive neurovascular devices are likely to experience substantial sales growth and improve their competitive positioning in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Trade Analysis

Global Neurovascular Devices Market Size by Disease Pathology & CAGR (2025-2032)

• Market Overview
• Cerebral Aneurysms
  • Embolic Coils
  • Bare Detachable Coils
  • Coated Detachable Coils
  • Flow Diversion Devices
  • Intracranial Stents
  • Microcatheters
  • Guidewires
• Ischemic Strokes
  • Clot Retriever Devices
  • Suction & Aspiration Devices
  • Vascular Snares
  • Microcatheters
  • Microguidewires
  • Balloon Catheters
• Carotid Artery Stenosis
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Balloon Catheters
• Arteriovenous Malformation & Fistulas
  • Liquid Embolic Agents
  • Occlusion Balloon Catheters
  • Microcatheters
• Other Disease Pathologies

Global Neurovascular Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals And Surgical Centers
• Ambulatory Care Centers
• Research Laboratories and Academic Institutes

Global Neurovascular Devices Market Size & CAGR (2025-2032)

• North America (Disease Pathology, End User)
  • US
  • Canada
• Europe (Disease Pathology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Pathology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Pathology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Pathology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imperative Care Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perflow Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WL Gore & Associates (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (United States) (duplicate)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InspireMD, Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations